Literature DB >> 28546796

Evidence-Based Approach to Clostridium difficile Infection.

Stuart Johnson1.   

Abstract

Entities:  

Year:  2017        PMID： 28546796      PMCID： PMC5441026     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  9 in total

1.  Fidaxomicin versus vancomycin for Clostridium difficile infection.

Authors:  Thomas J Louie; Mark A Miller; Kathleen M Mullane; Karl Weiss; Arnold Lentnek; Yoav Golan; Sherwood Gorbach; Pamela Sears; Youe-Kong Shue
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

2.  Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

Authors:  Christine H Lee; Theodore Steiner; Elaine O Petrof; Marek Smieja; Diane Roscoe; Anouf Nematallah; J Scott Weese; Stephen Collins; Paul Moayyedi; Mark Crowther; Mark J Ropeleski; Padman Jayaratne; David Higgins; Yingfu Li; Neil V Rau; Peter T Kim
Journal:  JAMA       Date:  2016-01-12       Impact factor: 56.272

3.  Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.

Authors:  Susy S Hota; Valerie Sales; George Tomlinson; Mary Jane Salpeter; Allison McGeer; Bryan Coburn; David S Guttman; Donald E Low; Susan M Poutanen
Journal:  Clin Infect Dis       Date:  2016-11-09       Impact factor: 9.079

4.  Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

Authors:  Stuart Johnson; Thomas J Louie; Dale N Gerding; Oliver A Cornely; Scott Chasan-Taber; David Fitts; Steven P Gelone; Colin Broom; David M Davidson
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

5.  Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

Authors:  Mark H Wilcox; Dale N Gerding; Ian R Poxton; Ciaran Kelly; Richard Nathan; Thomas Birch; Oliver A Cornely; Galia Rahav; Emilio Bouza; Christine Lee; Grant Jenkin; Werner Jensen; You-Sun Kim; Junichi Yoshida; Lori Gabryelski; Alison Pedley; Karen Eves; Robert Tipping; Dalya Guris; Nicholas Kartsonis; Mary-Beth Dorr
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

6.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

Review 7.  Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.

Authors:  Oliver A Cornely; Dilip Nathwani; Cristina Ivanescu; Olatunji Odufowora-Sita; Peny Retsa; Isaac A O Odeyemi
Journal:  J Antimicrob Chemother       Date:  2014-07-28       Impact factor: 5.790

Review 8.  Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

Authors:  Zain Kassam; Christine H Lee; Yuhong Yuan; Richard H Hunt
Journal:  Am J Gastroenterol       Date:  2013-03-19       Impact factor: 10.864

9.  Effects of control interventions on Clostridium difficile infection in England: an observational study.

Authors:  Kate E Dingle; Xavier Didelot; T Phuong Quan; David W Eyre; Nicole Stoesser; Tanya Golubchik; Rosalind M Harding; Daniel J Wilson; David Griffiths; Alison Vaughan; John M Finney; David H Wyllie; Sarah J Oakley; Warren N Fawley; Jane Freeman; Kirsti Morris; Jessica Martin; Philip Howard; Sherwood Gorbach; Ellie J C Goldstein; Diane M Citron; Susan Hopkins; Russell Hope; Alan P Johnson; Mark H Wilcox; Timothy E A Peto; A Sarah Walker; Derrick W Crook
Journal:  Lancet Infect Dis       Date:  2017-01-25       Impact factor: 71.421
  9 in total
  1 in total

1.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Zev H Davidovics; Sonia Michail; Maribeth R Nicholson; Larry K Kociolek; Nikhil Pai; Richard Hansen; Tobias Schwerd; Aldo Maspons; Raanan Shamir; Hania Szajewska; Nikhil Thapar; Tim de Meij; Alexis Mosca; Yvan Vandenplas; Stacy A Kahn; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.